316 related articles for article (PubMed ID: 19962890)
21. Synthesis, structure elucidation and antibacterial evaluation of new steroidal -5-en-7-thiazoloquinoxaline derivatives.
Khan SA; Saleem K; Khan Z
Eur J Med Chem; 2008 Oct; 43(10):2257-61. PubMed ID: 18440096
[TBL] [Abstract][Full Text] [Related]
22. Facile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridines.
Sirisha K; Achaiah G; Reddy VM
Arch Pharm (Weinheim); 2010 Jun; 343(6):342-52. PubMed ID: 20496343
[TBL] [Abstract][Full Text] [Related]
23. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A
Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives.
Candéa AL; Ferreira Mde L; Pais KC; Cardoso LN; Kaiser CR; Henriques Md; Lourenço MC; Bezerra FA; de Souza MV
Bioorg Med Chem Lett; 2009 Nov; 19(22):6272-4. PubMed ID: 19819134
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
Carta A; Loriga M; Paglietti G; Mattana A; Fiori PL; Mollicotti P; Sechi L; Zanetti S
Eur J Med Chem; 2004 Feb; 39(2):195-203. PubMed ID: 14987828
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antibacterial activities of some 4,5-dihydro-1H-1,2,4-triazol-5-ones.
Yüksek H; Demirbaş A; Ikizler A; Johansson CB; Celik C; Ikizler AA
Arzneimittelforschung; 1997 Apr; 47(4):405-9. PubMed ID: 9150862
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems--a novel class of potential antibacterial, antifungal and antitubercular agents.
Mallikarjuna BP; Sastry BS; Suresh Kumar GV; Rajendraprasad Y; Chandrashekar SM; Sathisha K
Eur J Med Chem; 2009 Nov; 44(11):4739-46. PubMed ID: 19589626
[TBL] [Abstract][Full Text] [Related]
28. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides.
Fassihi A; Azadpour Z; Delbari N; Saghaie L; Memarian HR; Sabet R; Alborzi A; Miri R; Pourabbas B; Mardaneh J; Mousavi P; Moeinifard B; Sadeghi-Aliabadi H
Eur J Med Chem; 2009 Aug; 44(8):3253-8. PubMed ID: 19371979
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents.
Mugunthan G; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Carbohydr Res; 2011 Sep; 346(13):1760-6. PubMed ID: 21714959
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones.
Raghavendra NM; Thampi P; Gurubasavarajaswamy PM; Sriram D
Arch Pharm (Weinheim); 2007 Dec; 340(12):635-41. PubMed ID: 17994604
[TBL] [Abstract][Full Text] [Related]
32. Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations.
Tripathi RP; Yadav AK; Ajay A; Bisht SS; Chaturvedi V; Sinha SK
Eur J Med Chem; 2010 Jan; 45(1):142-8. PubMed ID: 19846238
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, antiviral, antituberculostic, and antibacterial activities of some novel, 4-(4-substituted phenyl)-6-(4-nitrophenyl)-2-(substituted imino)pyrimidines.
Siddiqui AA; Rajesh R; ; Alagarsamy V; De Clercq E
Arch Pharm (Weinheim); 2007 Feb; 340(2):95-102. PubMed ID: 17294402
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
37. New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
Ancizu S; Moreno E; Solano B; Villar R; Burguete A; Torres E; Pérez-Silanes S; Aldana I; Monge A
Bioorg Med Chem; 2010 Apr; 18(7):2713-9. PubMed ID: 20233660
[TBL] [Abstract][Full Text] [Related]
38. Quinoxaline derivatives. Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines.
el-Hawash SA; Habib NS; Fanaki NH
Pharmazie; 1999 Nov; 54(11):808-13. PubMed ID: 10603606
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents.
Joshi SD; Vagdevi HM; Vaidya VP; Gadaginamath GS
Eur J Med Chem; 2008 Sep; 43(9):1989-96. PubMed ID: 18207286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
